Andrew D. Goldberg
Director; Director, CEO and President · 3 filings · Latest: Jun 25, 2026
ACHIEVE LIFE SCIENCES, INC.
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TARS | Andrew D. Goldberg | Director | Jun 12, 2026 | Option Exercise | — | 2,954 | — | 19,654 |